|1|Pericardial, intra-abdominal, and subcutaneous adipose tissue in patients with major depressive disorder. (24433292)
Kahl K.G.... Hartung D.
|2|From Stress to Inflammation and Major Depressive Disorder: A Social Signal Transduction Theory of Depression. (24417575)
Slavich G.M.... Irwin M.R.
|3|Pooled analysis of adjunct extended-release quetiapine fumarate in patients with major depressive disorder according to ongoing SSRI or SNRI treatment. (24108148)
Bauer M.... Eriksson H.
|4|Neural correlates of free T3 alteration after catecholamine depletion in subjects with remitted major depressive disorder and in controls. (23954912)
Homan P.... Hasler G.
|5|Major depressive disorder symptoms in male and female young adults. (23651450)
Lopez Molina M.A.... Souza L.
|6|Differential impact of isolated psychotic symptoms on treatment outcome of major depressive disorder in the STAR*D cohort of Whites, Blacks and Latinos. (23489398)
Cassano P.... Mischoulon D.
|7|Epistatic interaction between CRHR1 and AVPR1b variants as a predictor of major depressive disorder. (23962971)
Szczepankiewicz A.... Hauser J.
|8|Acute working memory improvement after tDCS in antidepressant-free patients with major depressive disorder. (23370288)
Oliveira J.F.... Brunoni A.R.
|9|Genome-wide association analysis accounting for environmental factors through propensity-score matching: application to stressful live events in major depressive disorder. (23857890)
Power R.A.... Uher R.
|10|Neural activity to intense positive versus negative stimuli can help differentiate bipolar disorder from unipolar major depressive disorder in depressed adolescents: a pilot fMRI study. (24080517)
Diler R.S.... Phillips M.
|11|Trigeminal nerve stimulation in major depressive disorder: acute outcomes in an open pilot study. (23773978)
Cook I.A.... Leuchter A.F.
|12|Acute phase cognitive therapy for recurrent major depressive disorder: who drops out and how much do patient skills influence response? (23485420)
Jarrett R.B.... Thase M.E.
|13|Relief of depression and pain improves daily functioning and quality of life in patients with major depressive disorder. (23989033)
Lin C.H.... Chen C.C.
|14|Local control for identifying subgroups of interest in observational research: persistence of treatment for major depressive disorder. (23956114)
Faries D.E.... Obenchain R.L.
|15|Gender-specific suicide risk factors: a case-control study of individuals with major depressive disorder. (24434089)
Dalca I.M.... Turecki G.
|16|Predictors of depressive symptoms at hospital discharge in patients with major depressive disorder. (23428235)
Wedig M.M.... Miller I.W.
|17|No support for a role for BDNF gene polymorphisms rs11030101 and rs61888800 in major depressive disorder or antidepressant response in patients of Finnish origin. (23250003)
Illi A.... LehtimAoki T.
|18|Psychotherapy, antidepressants, and their combination for chronic major depressive disorder: a systematic review. (23870720)
Spijker J.... van Balkom A.J.
|19|Major depressive disorder in Africa and the Middle East: a systematic literature review. (24138647)
Travers K.U.... Mould J.F.
|20|Azapirone 5-HT1A receptor partial agonist treatment for major depressive disorder: systematic review and meta-analysis. (24262766)
Kishi T.... Iwata N.
|21|Quality of life in patients with major depressive disorder. (23715339)
Imam M.A.... Ali M.
|22|Brain Biopsy Findings Link Major Depressive Disorder to Neuroinflammation, Oxidative Stress, and Neurovascular Dysfunction: A Case Report. (24075735)
Najjar S.... Zagzag D.
|23|Temporal discounting in major depressive disorder. (24176142)
Pulcu E.... Elliott R.
|24|Screening for major depressive disorder in adults with cerebral glioma: an initial validation of 3 self-report instruments. (23229997)
Rooney A.G.... Grant R.
|25|Interpersonal sensitivity associated with return to work status following sick leave: a cross-sectional study among Japanese workers with major depressive disorder. (23466112)
Ogawa T.... Nomura S.
|26|Adjunctive pregabalin in partial responders with major depressive disorder and residual anxiety. (23277244)
Vitali M.... Fava M.
|27|Adjunctive atypical antipsychotic treatment for major depressive disorder: a meta-analysis of depression, quality of life, and safety outcomes. (23554581)
Spielmans G.I.... Tsai A.C.
|28|Real-world, open-label study to evaluate the effectiveness of mirtazapine on sleep quality in outpatients with major depressive disorder. (23857869)
Wang D.... Hao W.
|29|Association of serum homocysteine with major depressive disorder: results from a large population-based study. (23707477)
Nabi H.... Preisig M.
|30|Association between major depressive disorder and the norepinephrine transporter polymorphisms T-182C and G1287A: a meta-analysis. (23648227)
Zhao X.... Zhu G.
|31|Vilazodone hydrochloride, a combined SSRI and 5-HT1A receptor agonist for major depressive disorder. (23229074)
|32|Analysis of association between common SNPs in ErbB4 and bipolar affective disorder, major depressive disorder and schizophrenia in the Han Chinese population. (21993442)
Chen P.... Shi Y.
|33|Increases in amplitude of low-frequency fluctuations in left fronto-parietal area after duloxetine therapy in first-episode, drug-naA^ve, major depressive disorder with panic disorder patients. (23037667)
|34|Genome-wide association study of recurrent early-onset major depressive disorder. (20125088)
Shi J.... Levinson D.F.
|35|Agomelatine for the treatment of major depressive disorder. (21916789)
Carney R.M.... Shelton R.C.
|36|Effect of short-term antidepressant treatment on early maladaptive schemas in patients with major depressive and panic disorder. (22121857)
Atalay H.... BaA9daAsiAsek S.
|37|Efficacy, safety, and tolerability of Desvenlafaxine 50 mg/d for the treatment of major depressive disorder:a systematic review of clinical trials. (20944767)
Liebowitz M.R.... Tourian K.A.
|38|Association of the adrenergic alpha 2a receptor--1291C/G polymorphism with weight change and treatment response to mirtazapine in patients with major depressive disorder. (19401164)
Lee H.Y.... Lee M.S.
|39|Sex-specific interaction between MAOA promoter polymorphism and Apo epsilon 2 allele in major depressive disorder in the Chinese population. (19859025)
Lin C.H.... Lung F.W.
|40|Monoamine oxidase a and catechol-o-methyltransferase functional polymorphisms and the placebo response in major depressive disorder. (19593178)
Leuchter A.F.... Alpert J.E.
|41|Gene expression and association analyses of the phosphodiesterase 4B (PDE4B) gene in major depressive disorder in the Japanese population. (18785206)
Numata S.... Ohmori T.
|42|Is there protective haplotype of dysbindin gene (DTNBP1) 3 polymorphisms for major depressive disorder. (17964051)
Kim J.J.... Han C.
|43|Meta-analyses of genetic studies on major depressive disorder. (17938638)
LA^pez-LeA^n S.... van Duijn C.M.
|44|Brain metabolic changes associated with predispotion to onset of major depressive disorder and adjustment disorder in cancer patients--a preliminary PET study. (16684544)
Kumano H.... Mikuni M.
|45|Association study of two serotonin 1A receptor gene polymorphisms and fluoxetine treatment response in Chinese major depressive disorders. (16458487)
Yu Y.W.... Chen T.J.
|46|Analysis of SNP profiles in patients with major depressive disorder. (15927089)
KA/ks S.... Vasar E.
|47|Aripiprazole augmentation of antidepressants for the treatment of partially responding and nonresponding patients with major depressive disorder. (16259533)
Simon J.S.... Nemeroff C.B.
|48|Monocyte chemoattractant protein-1 (MCP1) promoter -2518 polymorphism may confer a susceptibility to major depressive disorder in the Korean population. (15296827)
Pae C.U.... Paik I.H.
|49|Beclomethasone-induced vasoconstriction in women with major depressive disorder. (14517580)
Coupland N.J.... Myrholm J.
|50|Psychosocial characteristics of adolescents with a past history of dysthymic disorder: comparison with adolescents with past histories of major depressive and non-affective disorders, and never mentally ill controls. (9105954)
Klein D.N.... Seeley J.R.